Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)

Neeraj Agarwal; Bradley A. McGregor; Benjamin L. Maughan; Tanya B. Dorff; William Kevin Kelly; Bruno Fang; Rana R. McKay; Parminder Singh; Lance C. Pagliaro; Robert Dreicer; Sandy Srinivas; Yohann Loriot; Ulka N. Vaishampayan; Sanjay Goel; Dominic Curran; Ashok Panneerselvam; Martin Schwickart; Toni K. Choueiri; Sumanta K. Pal

doi:10.1016/s1470-2045(22)00278-9

Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021) | Litlas